Latest Sanofi Stock News | NASDAQ:SNY | Benzinga

Benzinga

79613.920.9027%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

79613.920.9027%

Sanofi SA Stock News

SNYNASDAQ

Trade with Public

Trade with Public

$44.24

-0.09-0.2%

Last update: Sep 4, 4:44 PM

$44.26

-0.07-0.16%

OverviewNewsEarnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Latest Sanofi Stock News | NASDAQ:SNY | Benzinga

Get the latest news on Sanofi stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Sanofi performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, September 01, 2026

The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win
Vandana Singh

Thursday, August 27, 2026

QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
Benzinga News-desk

Monday, August 24, 2026

Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy
Snigdha Gairola

Tuesday, August 18, 2026

European Medicines Agency Concerns Prompt Sanofi To Pull Dupixent Indication
Vandana Singh
PRO
EU EMA Announces Sanofi Winthrop Industrie Wi...
Benzinga Newsdesk

Tuesday, August 11, 2026

Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)
Radhika Anilkumar Nadig

Monday, August 10, 2026

Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children
Benzinga News-desk

Tuesday, August 04, 2026

PRO
Nurix Therapeutics Earns $10M Milestone Payme...
Benzinga Newsdesk
PRO
Sanofi Secures EU Approval For MenQuadfi In I...
Benzinga Newsdesk

Thursday, July 30, 2026

Sanofi Says Weak Decision-Making Hurt Pipeline, Promises More Disciplined R&D
Vandana Singh
PRO
Sanofi shares are trading lower after the com...
Benzinga Newsdesk
PRO
Sanofi Sees FY2026 Sales $55.789B vs $55.850B...
Benzinga Newsdesk
PRO
Sanofi Q2 Adj. EPS $1.21 Beats $1.09 Estimate...
Benzinga Newsdesk

Friday, July 24, 2026

Sanofi Drops Dupixent Successor Candidate After Assessing Data
Vandana Singh
PRO
Sanofi Discontinues Amlitelimab Development I...
Benzinga Newsdesk

Thursday, July 16, 2026

Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
Daragh Thomas

Friday, July 10, 2026

Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug
Vandana Singh
PRO
Sanofi's Subcutaneous Sarclisa Escena Receive...
Benzinga Newsdesk

Wednesday, July 08, 2026

Sino Biopharma Accelerates Global Growth With GSK, AstraZeneca Partnerships
Vandana Singh
PRO
European Commission Seeks Feedback On Commitm...
Benzinga Newsdesk

Thursday, July 02, 2026

PRO
WHO Director-General Ghebreyesus Says He Cons...
Benzinga Newsdesk

Tuesday, June 30, 2026

Sanofi Reports Data From Nexviazyme Study, Says It Meets All Endpoints
Vandana Singh
PRO
Sanofi Says Nexviazyme Was Well Tolerated Wit...
Benzinga Newsdesk

Monday, June 29, 2026

EU Launches Antitrust Probe Into Sanofi Over Allegedly Misleading Flu Vaccine Claims (UPDATED)
Vandana Singh

Friday, June 26, 2026

PRO
European Commission Opens Investigation Of Sa...
Benzinga Newsdesk

Thursday, June 25, 2026

PRO
Sanofi Foundation Strengthens Focus On Future...
Benzinga Newsdesk

Tuesday, June 23, 2026

Europe Approves Sanofi's Multiple Sclerosis Drug Despite FDA Rejection
Vandana Singh
PRO
Sanofi Says Japan Approves Wayrilz For Persis...
Benzinga Newsdesk
PRO
Sanofi Secures EU Approval For Cenrifki As Fi...
Benzinga Newsdesk

Monday, June 22, 2026

PRO
MacroGenics To Receive $24.5M Milestone From ...
Benzinga Newsdesk
PRO
Sanofi shares are trading lower. Investors ma...
Benzinga Newsdesk
AbbVie Expands Immunology Footprint With Apogee $11 Billion Acquisition
Vandana Singh

Monday, June 15, 2026

FDA OKs Sanofi Diabetes Drug In Newly Diagnosed Pediatric Patients
Vandana Singh
PRO
On Friday, FDA Granted Accelerated Approval T...
Benzinga Newsdesk

Thursday, June 11, 2026

Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says
Vandana Singh

Wednesday, June 10, 2026

PRO
Sanofi Terminates MOBILIZE Phase 3 Study Of R...
Benzinga Newsdesk

Monday, June 08, 2026

PRO
Sanofi's Sarclisa Becomes First EU-Approved A...
Benzinga Newsdesk

Friday, June 05, 2026

PRO
Owkin Announces Multi-year Collaboration With...
Benzinga Newsdesk
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative
Vandana Singh

Thursday, June 04, 2026

PRO
Shares of pharmaceutical companies are tradin...
Benzinga Newsdesk

Tuesday, June 02, 2026

PRO
Sanofi Used Snowflake Cortex AI To Build Its ...
Benzinga Newsdesk

Thursday, May 28, 2026

PRO
Sanofi's Venglustat Receives FDA Priority Rev...
Benzinga Newsdesk

Monday, May 18, 2026

PRO
Sanofi Announces Data From ElevAATe Phase 2 T...
Benzinga Newsdesk

Saturday, May 16, 2026

FDA Drug Chief Tracey Hoeg Fired Days After After Marty Makary's Exit— Says Order Came From 'Way Above'
Mohd Haider

Wednesday, May 06, 2026

Why Novavax Stock Is Trading Higher On Wednesday?
Vandana Singh
PRO
'Sanofi Asks To Pull Diabetes Drug Out Of FDA...
Benzinga Newsdesk

Monday, May 04, 2026

PRO
Sanofi Expands Toronto AI Centre With $294M I...
Benzinga Newsdesk

Wednesday, April 29, 2026

Regeneron Flags FDA Delays For Eylea HD Prefilled Syringe
Vandana Singh

Friday, April 24, 2026

PRO
Sanofi Receives European Medicines Agency's C...
Benzinga Newsdesk

Thursday, April 23, 2026

FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat
Vandana Singh

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Eli Lilly and Co

Johnson & Johnson

AstraZeneca PLC

Novo Nordisk AS

Bristol-Myers Squibb Co

Takeda Pharmaceutical Co Ltd